Annual Cash & Cash Equivalents
$21.64 M
-$6.00 M-21.70%
December 1, 2023
Summary
- As of February 27, 2025, BIOA annual cash & cash equivalents is $21.64 million, with the most recent change of -$6.00 million (-21.70%) on December 1, 2023.
- During the last 3 years, BIOA annual cash & cash equivalents has fallen by -$6.00 million (-21.70%).
- BIOA annual cash & cash equivalents is now -21.70% below its all-time high of $27.64 million, reached on December 1, 2022.
Performance
BIOA Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Cash And Cash Equivalents
$334.47 M
+$175.39 M+110.25%
September 30, 2024
Summary
- As of February 27, 2025, BIOA quarterly cash and cash equivalents is $334.47 million, with the most recent change of +$175.39 million (+110.25%) on September 30, 2024.
- Over the past year, BIOA quarterly cash and cash equivalents has increased by +$312.83 million (+1445.34%).
- BIOA quarterly cash and cash equivalents is now at all-time high.
Performance
BIOA Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash And Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
BIOA Cash And Cash Equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -21.7% | +1445.3% |
| 3 y3 years | -21.7% | +1445.3% |
| 5 y5 years | -21.7% | +1445.3% |
BIOA Cash And Cash Equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -21.7% | at low | at high | +1445.3% |
| 5 y | 5-year | -21.7% | at low | at high | +1445.3% |
| alltime | all time | -21.7% | at low | at high | +1445.3% |
BioAge Labs Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $334.47 M(+110.2%) |
| Jun 2024 | - | $159.09 M(-8.6%) |
| Mar 2024 | - | $173.99 M(+703.9%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2023 | - | $21.64 M |
| Dec 2023 | $21.64 M(-21.7%) | - |
| Dec 2022 | $27.64 M | - |
FAQ
- What is BioAge Labs annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for BioAge Labs?
- What is BioAge Labs annual cash & cash equivalents year-on-year change?
- What is BioAge Labs quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for BioAge Labs?
- What is BioAge Labs quarterly cash and cash equivalents year-on-year change?
What is BioAge Labs annual cash & cash equivalents?
The current annual cash & cash equivalents of BIOA is $21.64 M
What is the all time high annual cash & cash equivalents for BioAge Labs?
BioAge Labs all-time high annual cash & cash equivalents is $27.64 M
What is BioAge Labs annual cash & cash equivalents year-on-year change?
Over the past year, BIOA annual cash & cash equivalents has changed by -$6.00 M (-21.70%)
What is BioAge Labs quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of BIOA is $334.47 M
What is the all time high quarterly cash and cash equivalents for BioAge Labs?
BioAge Labs all-time high quarterly cash and cash equivalents is $334.47 M
What is BioAge Labs quarterly cash and cash equivalents year-on-year change?
Over the past year, BIOA quarterly cash and cash equivalents has changed by +$312.83 M (+1445.34%)